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Abstract
Background: Implementation of Multi drug Therapy (MDT) regimen has resulted in the decline of the total
number of leprosy cases in the world. Though the prevalence rate has been declining, the incidence rate remains
more or less constant and high in South East Asian countries particularly in India, Nepal, Bangladesh, Pakistan and
Srilanka. Leprosy, particularly that of multibacillary type spreads silently before it is clinically detected. An early
detection and treatment would help to prevent transmission in the community. Multiplex PCR (M-PCR) technique
appears to be promising towards early detection among contacts of leprosy cases.
Methods: A total of 234 paucibacillary (PB) and 205 multibacillary (MB) leprosy cases were studied in a community
of an endemic area of Bankura district of West Bengal (Eastern India). They were assessed by smear examination for
acid-fast bacilli (AFB) and M-PCR technique. These patients were treated with Multidrug Therapy (MDT) as
prescribed by WHO following detection. A total of 110 MB and 72 PB contacts were studied by performing M-PCR
in their nasal swab samples.
Results: 83.4% of MB patients were observed to be positive by smear examination for AFB and 89.2% by M-PCR.
While 22.2% of PB patients were found to be positive by smear examination for AFB, 80.3% of these patients were
positive by M-PCR. Among leprosy contacts (using M-PCR), 10.9% were found to be positive among MB contacts
and 1.3% among PB contacts. Interestingly, two contacts of M-PCR positive MB cases developed leprosy during the
period of two years follow up.
Conclusion: The M-PCR technique appears to be an efficient tool for early detection of leprosy cases in
community based contact tracing amongst close associates of PB and MB cases. Early contact tracing using a
molecular biology tool can be of great help in curbing the incidence of leprosy further.
Background
From time immemorial, leprosy is a grossly mutilating
disease associated with social stigma and taboos, parti-
cularly in underdeveloped nations. The global caseload
of leprosy has reduced by almost 90% over the last 20
years and 15 million cases have been detected and cured
worldwide. Three hundred thousand (0.3 million) new
cases were detected during the year 2005 [1]. The prin-
cipal factor contributing to this worldwide success is
attributed to the introduction of standardized MDT
regimens against the causative agent, Mycobacterium
leprae. Further, leprosy elimination campaigns for case
d e t e c t i o ni nc o m m u n i t i e s ,t r a i n i n go fp h y s i c i a n sa n d
leprosy health care workers, community awareness
towards prevention and control of leprosy have also pro-
ven to be beneficial. Elimination is defined as a reduc-
tion in the prevalence of leprosy patients receiving
antibacterial therapy to less than 1 per 10,000 popu-
lations[2], which indicates that the disease is no longer
considered a major public health problem. India has
achieved the prevalence rate of less than 1 per 10,000
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in six countries of South East Asian region including
India. India alone accounted for 60% of the world’s
newly detected cases [1,3]. This might be due to lack of
consistent information on the core elements of this
infectious disease, e.g. source of infection, reservoir and
mode of transmission, host factors related to immunity
of disease etc [4-6]. It has been observed that though
prevalence has declined since initiation of MDT, the
incidence has not shown a similar decline during the
same period i.e. after implementation of MDT [7-10].
Leprosy, particularly MB type, is highly contagious
and infectious may spread to several contacts of patients
even before clinical diagnosis. In case of MB leprosy,
contacts staying in the same house are at higher risk of
getting infection compared to contacts staying at the
neighboring houses [10-14]. Therefore, early detection
of infections among close contacts followed by effective
chemotherapy is likely to bring down the spread of dis-
ease leading to a decline in the overall incidence rate.
Unfortunately, the conventional method of contact tra-
cing fails to detect fresh cases before it becomes trans-
missible to others (person to person transmission) [15]
Hence, it is necessary to have an alternative and more
effective tool for an early detection to prevent and con-
trol further transmission.
Previous work carried out by us, has led to the devel-
opment of a Multiplex PCR (M-PCR) for early diagnosis
of leprosy. The technique was standardized and was
evaluated with high sensitivity and specificity [16].
The present study was carried out to evaluate whether
the same technique could be used as a better diagnostic
tool for early detection of leprosy cases and contacts for
prediction of future cases of leprosy.
Methods
Patients
This study was conducted in an endemic population in
the district of Bankura (prevalence rate greater than 2
per 10,000 populations) in West Bengal, India. After
taking formal consent, a total no of 234 paucibacillary
(PB) and 205 multibacillary cases (MB) attending the
Public Health Centers were assessed by AFB (Acid Fast
Bacilli) smear examination as well as multiplex-PCR (M-
PCR) to assess the diagnostic efficiency of the later. Out
of 234 PB cases 140 were tuberculoid (TT) and 94 were
borderline tuberculoid (BT). Similarly, of 205 MB cases
53 were borderline lepromatous (BL) and 152 were
lepromatous leprosy (LL)
Patients were grouped in the following categories:
(i) Patients without treatment, (ii) Patients on treat-
ment not more than two months, (iii) Patients com-
plaining of hypoesthesia but showing no clinical
symptoms of leprosy - considered as Indeterminate type,
and (iv) Patients released from treatment (RFT) and
later developed a new active lesion/i.e. relapsed cases.
Slit skin smear (SSS) for acid -fast bacilli (AFB) stain-
ing were obtained from all patients for determination of
Bacterial Index (BI). All diagnosed cases were given
MDT as per the national leprosy control programmed
guidelines [17]. Competent health care workers followed
up household contacts of these patients. A total of 182
persons of which 110 were MB contacts and 72 were PB
contacts, participated in this study voluntarily. Nasal
swabs/slit skin smear specimens were obtained from all
contacts after obtaining their necessary consent. The
contacts were followed up for two years for observing
the development of clinical leprosy.
Ethical approval was taken from the Ethical Commit-
t e eo ft h eI n s t i t u t e( O f f i c eo ft h eD i r e c t o r ,I n s t to fP o s t
Graduate Medical Education & Research, Kolkata, Govt.
Of West Bengal). Ref No. Inst/IEC/1835 dated 2.8.05 as
a part of the project entitled “Development of Multiplex
PCR for Early Diagnosis and Strain Differentiation of M.
leprae“ and since then reviewed periodically.
Sample collection
Slit Skin Smear: SSS were obtained from each patient
(from 3 to 6 sites, depending on the type of leprosy) for
determination of bacterial index (BI). 4 mm punch
biopsy/SSS from three to six sites for each patient were
obtained. Half of the biopsy samples from each patient
was used for paraffin embedded sectioning and the other
portions were stored at -20°C until PCR was performed.
BI (bacteriological index) was also determined microsco-
pically from paraffin section of biopsy specimens.
Collection of Nasal Swabs: The surface of the nasal
septum either side of each patient were swabbed with
sterilized wet cotton swabs, frozen in buffered saline
containing 0.05% Tween80, which released the sample
from cotton swabs. The aliquot was centrifuged at
10,000X g. The sediment was processed for DNA
extraction as described bellow.
DNA Extraction from clinical samples
Extraction of DNA
a) From Skin Tissues: The Frozen section of tissues/skin
biopsy specimens were cut to small pieces with sterile
scissors. These samples were homogenized in a manual
homogenizer with 1 ml sterile distilled water. It was
then incubated in lyses buffer containing 300 μlo f1 0 0
mM Tris-HCl, pH8.5 (containing 0.05% Tween 20 and
60 μg of proteinase K per ml) for 18hrs at 60°C. Paraffin
oil (40 μl) was layered on top of the buffer to prevent
evaporation. Thereafter, the samples were incubated at
97°C for 15 minutes [11], followed by heating for inacti-
vation of proteinase K. Equal volume of phenol-chloro-
form-isoamyl alcohol (25:24:1) was later layered on the
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Page 2 of 8lysed homogenated product. The tube was shaken vigor-
ously for 1 minute. After centrifugation of the material
for 8 minutes, the aqueous phase was collected and
again mixed with an equal volume of chloroform-isoa-
myl alcohol. This was followed up by another brief cen-
trifugation. Then, the uppermost phase was collected
and boiled for 10 minutes to destroy DNase, followed
by precipitation of DNA with ethanol. The precipitated
DNA was resuspended in 100 μl of distilled water and
used for M-PCR.
b)Extraction of DNA from Nasal swab: Frozen samples
were quickly thawed and centrifuged at 10,000X g for 20
minutes The sediment was subjected to DNA extraction
following the same procedure as mentioned above.
Multiplex PCR
A M-PCR was developed in our laboratory [16] based
on:
(a) Primers amplifying the 372 bp of the repetitive
sequence of M.leprae, known to be specific for M.leprae and
is not present in twenty other mycobacterial species [19].
(b) A pair of primers was designed to amplify 201 bp
flanking entire21 TTC repeats [20].
Sequences for (a): 5′-CGG CCG GAT CCT CGA TGC
AC-3′ (primerR1)
5′-GCA CGT AAG CTT GTC GGT GG-3′ (primerR2)
For (b): 5′-GGA CCT AAA CCA TCC CGT TT-3′
(TTC-A)
5′-CTA CAG GGG GCA CTT AGC TC-3′ (TTC-B)
Reaction mixtures, conditions of reactions and cycling
conditions were optimized as follows:
The reaction mixture contains 50 ul of 10 mMTris-
HCL(pH 8.3), 50 mMKCL, 1.5 MgCl2, 0.01% (wt/Vol)
gelatin, 200 uM each dATP, dGTP, dCTPand dTTP, 1U
of Taq polymerase(Perkin -Elmer Cetus, Norwalk,
Conn)0.5 μm each primer and DNA extracted from
biopsy samples.
PCR Condition: PCR is carried out in a thermocycler
for 35 cycles consisting of denaturation at 94°C for 1
min, annealing at 60°C for 2 mins and primer extension
at 72°C for 3 mins. After purified DNA is added to the
PCR mix, triple distilled water is used as negative con-
trol. The tubes are kept for at least 10 mins at room
temperature. After amplification is finished, a 20 μl por-
tion of the reaction mixture is run in a 2% agarose gel.
After electrophoresis, the gel is stained with ethidium
bromide, and the 372 bp and 201 bp bands examined
under UV illumination.
Statistical Analysis
Sensitivity of smear examination for AFB and M-PCR of
skin biopsy samples is calculated considering clinically
diagnosed cases as true gold standard of positivity.
Results
The findings of M-PCR and BI of SSS are presented in
table 1.
From the above table it is clear, that on the whole M-
PCR can detect a higher number (79.2% to 89.4%) of
leprosy cases compared to SSS test (19.1% to 87.5%). The
sensitivity of M-PCR in case of tuberculoid type is higher
than smear examination. It is noted that the positivity was
considerably higher in tuberculoid cases (TT 79%, BT
81.9%) in comparison to SSS (TT 31.4%, BT 19.1%). Multi-
plex PCR of nasal swab was found to be positive 49.4%
(42/85), 51.6% (32/62), 62.5% (25/40) and 78.1% (75/96) in
the categories of TT, BT, BL and LL respectively. This
indicates that nasal swab could be an alternative, non-
invasive procedure for M- PCR for leprosy detection. PCR
results were confirmed by sequencing. (Figure -1)
T h ed a t ao b t a i n e df r o mM - P C Ro fn a s a ls w a bo f1 1 0
household contacts of MB patients and 72 of PB
patients are presented in table 2. The result shows that
11.7% adults and 9.5% children among MB contacts and
2% adult among PB contacts showed evidence of M
leprae DNA in their nasal swabs. These contacts were
followed up prospectively for two years since the day of
collection of nasal swabs. It was observed that 1 adult
Table 1 Sensitivity of AFB and multiplex-PCR as diagnostic tools in detecting paucibacillary as well as multibacillary
leprosy cases among clinically diagnosed patients
Type of disease Clinical
Forms
Cases confirmed by
AFB In SSS
(Slit skin smear)
Cases confirmed by
Multiplex-PCR
Percent of positivity by
AFB test
Percent of positivity of
M-PCR test
Paucibacillary cases
(n = 234)
TT (n =
140)
44 (BI < 2) 111 31.4% 79.2%
BT (n = 94) 18 (BI < 2) 77 19.1% 81.9%
Total 234 52 188 22.2% 80.3%
Multibacillary cases (n
= 205)
BL (n = 53) 38 (BI > 2) 47 71.6% 88.6%
LL (n =
152)
133 (BI > 2) 136 87.5% 89.4%
Total 205 171 183 83.4% 89.2%
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contacts during the two-year observation period. None
of the contacts from PB cases developed clinical leprosy
during the follow up period (table-2)
Discussion
Leprosy is a disease with long incubation period and the
symptoms are difficult to perceive at the early stage of
infection. Self-healing does occur in a large number of
infected cases. Moreover many patients with early signs
are not aware that they are suffering from leprosy and
thus clinical diagnosis is often delayed. Clinical diagnosis
is possible only when the patient is symptomatic, exhi-
biting lesions and satisfies the criteria of cardinal signs
of leprosy [23]. A sizable proportion of new cases are
among children (WHO 2004),[21] as they often remain
Figure 1 Sequencing report.
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same dwelling units that facilitate infection in them [22]
Similarly, an infected child could pass this infection to
other children while they are in contact for longer dura-
tion, i.e, playing in a group or in school. This often goes
un-noticed during initial phase because of its slow and
silent nature of early transmission.
Considering the above, early detection of cases fol-
lowed by effective chemotherapy appears to be the single
most effective strategy for reducing incidence of leprosy
cases as well as to prevent transmission. However, exist-
ing method of contact tracing and detection is not
beyond criticism. The results of M-PCR that was devel-
oped and used in this pilot study as an alternative tool
appears to be encouraging. In our study using M-PCR,
we found that the molecular tool is much better in
detecting high percentage of TT/BT cases (79.2% &
81.9% respectively), than cases detected by SSS (22.2%).
The overall positivity of PB cases by PCR is 80.3%. As the
disease progresses further, the positivity of both PCR
(80.3% to89.2%) and AFB smear examination are (22.2%
to83.4%) increased. This efficacy of M-PCR over SSS can
be explained by the fact that, with the progression of dis-
ease there is increase of bacterial load resulting in avail-
a b i l i t yo fm o r eg e n o m i cD N Ao fMl e p r a eand thereby
leading to PCR positivity. While specific PCR for diagno-
sis of leprosy developed by previous scientists [27,28]
were successful in diagnosing only 50% of PB cases, the
present M-PCR was able to diagnose 80.34% of PB cases.
The reason for identifying more cases of early infection
might be due to the use of combination of two specific
primers in the same PCR reaction. However, unlike the
previous workers, the M-PCR failed to detect 100% cases
of MB leprosy. The reason for the failure may be due to
the inclusion of large number of cases (205) compared to
those of 37[28] and 38 [27] cases of MB leprosy. From
table 3 and 4 it is seen that MPCR is highly sensitive in
new cases and the sensitivity gradually decreases in case
of RFT/Relapse cases both in PB and MB patients. This
result is along expected lines, as it is difficult to amplify
mycobacterial DNA in patients after treatment due to
genomic degradation of the bacteria. The specificity was
not calculated in this study as the same was done in our
earlier study while evaluating MPCR as a diagnostic tool
and it was found to be very high [16]. From the present
study, it can be suggested that M-PCR could be an alter-
native screening tool for detection of early leprosy cases
or their close contacts with high sensitivity compared to
any other available tools.
Another important and effective strategy for reduction
of incidence of leprosy is contact tracing and early
detection of cases among them. In our pilot study M-
PCR technique was applied in the leprosy contacts for
adopting a better way of community-based early case
detection. Contacts of PB and MB cases both were fol-
lowed up after testing their nasal swabs by M-PCR. It
was noted that two of the twelve M-PCR positive cases
developed as clinical cases and none of the M- PCR
negative cases developed any form of leprosy during this
period. It is interesting to note that a significantly larger
numbers (12 numbers) of MB contacts were positive by
M - P C Rt h a nt h a to fP Bc o n t a c t s( 2n u m b e r s )w h od i d
not develop leprosy during the follow up period.
It has been estimated that 6-8% of household contacts
develop clinical symptoms of leprosy within two years of fol-
low up since the diagnosis of the index cases[24]. In our
study 10.9% MB contacts were PCR positive and 1.8% devel-
oped the disease within two years of study period. This low
number of detection in our study group could be due to the
lower transmission dynamics in the community during the
post elimination era. Keeping in mind the long incubation
period of the disease it is imperative that the contacts need
to be followed and observed for a longer period.
The trend that we find in our study can serve as
important clue that the contacts of MB patients are at
increased risk of developing leprosy in the future. This
hypothesis needs to be tested on large scale of popula-
tion over a long interval before coming to any conclu-
sion, since the authors have no intention to put forth
the MB patients into social ostracism under the fear of
infection. Whatever the relationship between positivity
of PCR and development of the disease, PCR is much
more sensitive than microscopic examination for direct
detection of bacilli [25,26]. Moreover, at present there is
no other more sensitive alternative tool available for
early detection of leprosy other than PCR and
Table 2 Showing M-PCR positivity and incidence of leprosy in household contacts of leprosy cases in nasal swabs
Multibacillary leprosy contact Paucibacillary leprosy contact
Number of
persons tested
with M-PCR
(Nasal Swab)
Number
positive
(%)
Development of leprosy cases
among contacts within 2 year
follow up
Number of persons
tested with M-PCR
(Nasal Swab)
Number
positive
(%)
Development of leprosy cases
among contacts within 2 year
follow up
Adult = 68 8 (11.7%) 1 Adult = 48 1 (2%) 0
Child = 42 4 (9.5%) 1 Child = 24 0 (0%) 0
Total = 110 12 (10.9%) 2 Total = 72 1 (1.3%) 0
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dardized based on the presence of M. leprae DNA
which does not support the presence of viable organ-
i s m s .E f f o r ts h o u l db em a d et os t a n d a r d i z eam e t h o d
based on mRNA detection so that viability of M. leprae
bacilli could also be ascertained [27-30].
It should be also noted that the PCR positivity in con-
tact persons indicate the presence of M. leprae DNA
only and not infection and therefore, a careful follow up
of them should be done and treatment should be started
immediately after the development of first sign and
symptoms of leprosy.
Conclusion
This study indicates that M-PCR can be used as an effi-
cient tool for early detection of leprosy among contacts.
Table 3 Sensitivity of AFB and multiplex-PCR as diagnostic tools in detecting multibacillary leprosy cases among
different categories of multibacillary patients
BL n = 53
Clinical status of the disease Cases confirmed by AFB
In SSS(Slit skin smear)
Cases confirmed
by Multiplex-PCR
Percent of positivity
by AFB test
Percent of positivity
of M-PCR test
BI No of case
Patients without treatment (New Cases)(n = 44) 2 23 23 100% 100%
31 1 1 1
41 0 1 0
Patients on treatment not more than 2 months
(n = 5)
0 4 2(50%) 25% 60%
21 1
30 0
40 0
Patients released from treatment (RFT)
(a)/later
developed a new active lesion/relapsed cases
(b)
(n = 4)
02
a, 2(0%) 50% 50%
21
a 1
a
31
b 1
b
Total n = 53 71.6% (38/53) 88.67% (47/53)
LL n = 152
Clinical status of the disease Cases confirmed by AFB
In SSS(Slit skin smear)
Cases confirmed by
Multiplex-PCR
Percent of positivity
by AFB test
Percent of positivity
of M-PCR test
BI No of case
Patients without treatment (New Cases)
(n = 115)
2 8 8 100% 100%
33 5 3 5
43 7 3 7
53 1 3 1
64 4
Patients on treatment not more than 2 months
(n = 12)
0 4 1(25%) 66.66% 75%
23 3
32 2
43 3
50 0
60 0
Patients released from treatment (RFT)
(a)/later
developed a new active lesion/relapsed cases
(b)
(n = 25)
01 4
a,1
b 2(13.33%) 40% 48%
21
a,2
b 3
32
b 2
42
a,1
b 3
51
a 1
61
a 1
Total n = 152 83.4% (133/152) 89.2% (136/152)
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population size and controls over a long period of time.
As this M- PCR can only detect the presence of M.
leprae DNA, hence a contact with positive PCR result
must be followed up regularly for detection of any
development of disease. As leprosy has a long and varied
incubation period, a long term follow up/observation is
necessary to establish clearly the early case detection
efficiency of M- PCR.
This M- PCR is a relatively expensive procedure com-
pared to other methods of detection of infection caused
by M. leprae. It has its limitations in the viability detec-
tion of the bacteria. In addition, it also requires a well-
equipped laboratory which is difficult to replicate in the
field. When tests are performed in bulk, the cost is
expected to go down significantly. Hence, we recom-
mend its application in a large number of samples to
make it cost effective. The test needs to be evaluated
further as it could serve as a better diagnostic tool for
early case detection and their treatment to achieve faster
control of leprosy.
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